Home › Atopic Dermatitis (Eczema) › NCT06136767
Registry for Systemic Eczema Treatments
RecruitingObservational study
Who can join
Ages 1 to 26 · All sexes
Full eligibility criteria
Inclusion criteria: * Age \<26 years old * Current physician diagnosis of atopic dermatitis * Provide signed informed consent if ≥ 18 years old * Provide signed informed consent by parent or legal guardian (if \<18 years old) and informed assent if applicable * Subject and/or parent/legal guardian is willing to be contacted in the future by study staff * Seen for clinical care at Johns Hopkins since 1/1/2017 * Previously on, currently on, or planning to initiate (within next 6 months) a systemic AD therapy Exclusion criteria: * Age ≥26 years old at the time of registry enrollment * Does not speak English * If \<18 years old, has a primary caretaker who does not speak English * If \<18 years old, parent/legal guardian is unwilling to sign the written informed consent * Is a foster child * Has not received clinical care at Johns Hopkins since 1/1/2017
About the study
The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.
Sponsor: Johns Hopkins University · Participants: 400 · Started: Jan 17, 2024
Contact the study team
- Zeena Mestari, BA · Phone: 1 (848) 702-4101‬
- Rebecca Urbonas, BS · Phone: 813-300-1317
Official record on ClinicalTrials.gov — NCT06136767
Locations in the U.S.
| Maryland | Johns Hopkins University, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.